Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences


Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at three upcoming investor conferences:

Citizens JMP Life Sciences Conference
Fireside Chat: Tuesday, May 14, 2024 at 1:30 p.m. Eastern Time in New York, NY

2024 RBC Capital Markets Global Healthcare Conference
Fireside Chat: Wednesday, May 15, 2024 at 11:30 a.m. Eastern Time in New York, NY

BofA Securities Health Care Conference
Fireside Chat: Wednesday, May 16, 2024 at 12:20 p.m. Eastern Time in Las Vegas, NV

Live webcasts of each fireside chat will be accessible on the company's website, Acadia.com, under the investors section and an archived recording will be available on the website for approximately one month following each presentation.

About Acadia Pharmaceuticals

Acadia is advancing breakthroughs in neuroscience to elevate life. For 30 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only FDA-approved drug to treat hallucinations and delusions associated with Parkinson's disease psychosis and the first and only FDA-approved drug for the treatment of Rett syndrome. Our clinical-stage development efforts are focused on Prader-Willi syndrome, Alzheimer's disease psychosis and multiple other programs targeting neuropsychiatric symptoms in central nervous system disorders. For more information, visit us at Acadia.com and follow us on LinkedIn and Twitter.


These press releases may also interest you

at 12:07
Pet parents may fear their pets' aging ? because "growing old" is associated with slowing down and losing some of the spirit and vibrancy that makes them special. That's why Hill's Pet Nutrition (Hill's) is teaming up with actress and senior pet...

at 12:00
The American Society for Gastroenterology and Endoscopy (ASGE) announced today the launch of the Artificial Intelligence Institute for Gastroenterology, a milestone initiative to integrate artificial intelligence (AI) into gastrointestinal (GI) care,...

at 12:00
Healthly, a future-forward healthcare organization, is pleased to announce Wayne Dysinger, M.D., Master of Public Health (MPH), Diplomate of the American Board of Lifestyle Medicine (ABLM), Fellow and Past President of the American College of...

at 12:00
As You Are, the nation's leading telehealth provider of pediatric autism evaluations, announces a collaboration with Included Health, a new kind of healthcare company delivering virtual care and navigation for millions of people nationwide....

at 12:00
Cantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other life-threatening medical conditions for which new treatments are urgently needed, announced today that the U.S....

at 12:00
In anticipation of commercial launch of the AlphaION Point of Care diagnostic platform, Center Point Bio-Tech, LLC ("CP Bio") entered into a non-exclusive distribution agreement with a well-known and highly respected veterinary distributor...



News published on and distributed by: